RHCE variant alleles and risk of alloimmunization in Brazilians

1. Avent ND, Reid ME. The Rh blood group system: a review. Blood 2000;95:375–87. Avent ND Reid ME. The Rh blood group system: a review . Blood 2000 ; 95 : 375 – 87 . 10.1182/blood.V95.2.375 Search in Google Scholar

2. Noizat-Pirenne F, Tournamille C. Relevance of RH variants in transfusion of sickle cell patients. Transfus Clin Biol 2011;18:527–35. Noizat-Pirenne F Tournamille C. Relevance of RH variants in transfusion of sickle cell patients . Transfus Clin Biol 2011 ; 18 : 527 – 35 . 10.1016/j.tracli.2011.09.00122024128 Search in Google Scholar

3. Chou ST, Evans P, Vege S, et al. RH genotype matching for transfusion support in sickle cell disease. Blood 2018;132: 1198–207. Chou ST Evans P Vege S RH genotype matching for transfusion support in sickle cell disease . Blood 2018 ; 132 : 1198 – 207 . 10.1182/blood-2018-05-85136030026182 Search in Google Scholar

4. Chou ST, Flanagan JM, Vege S, et al. Whole-exome sequencing for RH genotyping and alloimmunization risk in children with sickle cell anemia. Blood Adv 2017;1:1414–22 Chou ST Flanagan JM Vege S Whole-exome sequencing for RH genotyping and alloimmunization risk in children with sickle cell anemia . Blood Adv 2017 ; 1 : 1414 – 22 .10.1182/bloodadvances.2017007898572785629296782 Search in Google Scholar

5. Chou ST, Jackson T, Vege S, Smith-Whitley K, Friedman DF, Westhoff CM. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood 2013;122:1062–71. Chou ST Jackson T Vege S Smith-Whitley K Friedman DF Westhoff CM. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors . Blood 2013 ; 122 : 1062 – 71 . 10.1182/blood-2013-03-49062323723452 Search in Google Scholar

6. Gaspardi AC, Sippert EA, De Macedo MD, Pellegrino J Jr, Costa FF, Castilho L. Clinically relevant RHD-CE genotypes in patients with sickle cell disease and in African Brazilian donors. Blood Transfus 2016;14:449–54. Gaspardi AC Sippert EA De Macedo MD Pellegrino J Jr Costa FF Castilho L. Clinically relevant RHD-CE genotypes in patients with sickle cell disease and in African Brazilian donors . Blood Transfus 2016 ; 14 : 449 – 54 . Search in Google Scholar

7. Sippert E, Fujita CR, Machado D, et al. Variant RH alleles and Rh immunisation in patients with sickle cell disease. Blood Transfus 2015;13:72–7. Sippert E Fujita CR Machado D Variant RH alleles and Rh immunisation in patients with sickle cell disease . Blood Transfus 2015 ; 13 : 72 – 7 . Search in Google Scholar

8. Keller MA, Mansfield P, Maurer J, et al. Identifying compatible blood for RH alloimmunized patients: an international case. 29th Regional Congress of ISBT (Abstract P-036). Vox Sang 2019;114:85. Keller MA Mansfield P Maurer J Identifying compatible blood for RH alloimmunized patients: an international case. 29th Regional Congress of ISBT (Abstract P-036) . Vox Sang 2019 ; 114 : 85 . Search in Google Scholar

9. Floch A, Tournamille C, Chami B, Pirenne F. Genotyping in sickle cell disease patients: the French strategy. Transfus Med Hemother 2018;45:264–70. Floch A Tournamille C Chami B Pirenne F. Genotyping in sickle cell disease patients: the French strategy . Transfus Med Hemother 2018 ; 45 : 264 – 70 . 10.1159/000490858615858030283276 Search in Google Scholar

10. Higgins JM, Sloan SR. Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders. Blood 2008;112:2546–53. Higgins JM Sloan SR. Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders . Blood 2008 ; 112 : 2546 – 53 . 10.1182/blood-2008-03-14641518535200 Search in Google Scholar

11. Yazdanbakhsh K, Ware RE, Noizat-Pirenne F. Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood 2012;120: 528–37. Yazdanbakhsh K Ware RE Noizat-Pirenne F. Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management . Blood 2012 ; 120 : 528 – 37 . 10.1182/blood-2011-11-327361340121322563085 Search in Google Scholar

12. Silvy M, Tournamille C, Babinet J, et al. Red blood cell immunization in sickle cell disease: evidence of a large responder group and a low rate of anti-Rh linked to partial Rh phenotype. Haematologica 2014;99:e115–7. Silvy M Tournamille C Babinet J Red blood cell immunization in sickle cell disease: evidence of a large responder group and a low rate of anti-Rh linked to partial Rh phenotype . Haematologica 2014 ; 99 : e115 – 7 . 10.3324/haematol.2014.104703407709824727821 Search in Google Scholar

13. Tormey CA, Hendrickson JE. Transfusion-related red blood cell alloantibodies: induction and consequences. Blood 2019;133:1821–30. Tormey CA Hendrickson JE. Transfusion-related red blood cell alloantibodies: induction and consequences . Blood 2019 ; 133 : 1821 – 30 . 10.1182/blood-2018-08-833962648438530808636 Search in Google Scholar

14. Thonier V. Immuno-hematological findings in delayed hemolytic transfusion reaction (DHTR). Transfus Clin Biol 2019;26:102–8. Thonier V. Immuno-hematological findings in delayed hemolytic transfusion reaction (DHTR) . Transfus Clin Biol 2019 ; 26 : 102 – 8 . 10.1016/j.tracli.2019.02.00630885514 Search in Google Scholar

15. Floch A. Molecular genetics of the Rh blood group system: alleles and antibodies—a narrative review. Ann Blood 2021;6:29 Floch A. Molecular genetics of the Rh blood group system: alleles and antibodies—a narrative review . Ann Blood 2021 ; 6 : 29 10.21037/aob-20-84 Search in Google Scholar

16. Arnoni CP, Vendrame T, Muniz J, Cortez A, Latini F, Castilho L. RHCE diversity among Brazilian patients with sickle cell disease (SCD) and selected groups of blood donors. Transfusion 2021;61:3473–82. Arnoni CP Vendrame T Muniz J Cortez A Latini F Castilho L. RHCE diversity among Brazilian patients with sickle cell disease (SCD) and selected groups of blood donors . Transfusion 2021 ; 61 : 3473 – 82 . 10.1111/trf.1668934590710 Search in Google Scholar

17. Pirenne F, Yazdanbakhsh K. How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions. Blood 2018;131:2773–81. Pirenne F Yazdanbakhsh K. How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions . Blood 2018 ; 131 : 2773 – 81 . 10.1182/blood-2018-02-785964601435429724898 Search in Google Scholar

18. Petz LD, Calhoun L, Shulman IA, Johnson C, Herron RM. The sickle cell hemolytic transfusion reaction syndrome. Transfusion 1997;37:382–92. Petz LD Calhoun L Shulman IA Johnson C Herron RM. The sickle cell hemolytic transfusion reaction syndrome . Transfusion 1997 ; 37 : 382 – 92 . 10.1046/j.1537-2995.1997.37497265338.x9111275 Search in Google Scholar

19. Moller M, Joud M, Storry JR, Olsson ML. Erythrogene: a database for in-depth analysis of the extensive variation in 36 blood group systems in the 1000 Genomes Project. Blood Adv 2016;1:240–9. Moller M Joud M Storry JR Olsson ML. Erythrogene: a database for in-depth analysis of the extensive variation in 36 blood group systems in the 1000 Genomes Project . Blood Adv 2016 ; 1 : 240 – 9 . 10.1182/bloodadvances.2016001867573716829296939 Search in Google Scholar

20. Tournamille C, Meunier-Costes N, Costes B, et al. Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization. Transfusion 2010;50:13–9. Tournamille C Meunier-Costes N Costes B Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization . Transfusion 2010 ; 50 : 13 – 9 . 10.1111/j.1537-2995.2009.02382.x19778340 Search in Google Scholar